Quantum
Home > Boards > US OTC > Miscellaneous >

MiMedx Group Inc. (MDXG)

MDXG RSS Feed
Add MDXG Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/13/2018 6:17:20 PM - Followers: 29 - Board type: Free - Posts Today: 0

 



           
 





Feb 2013 Investor Presentation:

http://www.mimedx.com/media/pdf/MDXG%20Investor%20presentation%20020213.pdf




Investor Introduction:

About MiMedx

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products processed from human amniotic membrane.

"Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarian births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® Process to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 100,000 implants to date to distributors and OEMs for applications in the Ophthalmic, Orthopedic, Spine, Wound Care, and Dental sectors of healthcare.

Our platform technologies, AmnioFix®, EpiFix®, HydroFix® and CollaFix™, have such a vast number of potential applications in treating traumatized tissue and structures that it is difficult to accurately quantify. MiMedx Group is focused on commercializing multiple applications of all four technologies. In parallel, we are seeking strategic relationships to more rapidly commercialize our technologies.
AmnioFix®, EpiFix®, HydroFix®and CollaFix™are trademarks of MiMedx Group, Inc.

 

Contact and Stock Information

MiMedx Group, Inc.
60 Chastain Center Boulevard
Suite 60
Kennesaw, GA 30144

Phone: 678-384-6720
Website: http://www.mimedx.com

Estimated Market Cap : $286.26M as of Dec 18, 2012

Outstanding Shares 86.7M as of December 18, 2012

Float: 66.68M as of December 18, 2012

Parker H. "Pete" Petit - Chairman of the Board and Chief Executive

Mr. Petit was Chairman and CEO of Matria Healthcare which was sold to Inverness Medical Innovations in May of 2008. Matria Healthcare was a former subsidiary of Healthdyne, which Mr. Petit founded in 1970. Mr. Petit served as Chairman and CEO of Healthdyne and several of its publicly traded subsidiaries after Healthdyne became a publicly traded company in 1981. One of Healthdyne's other subsidiaries, Healthdyne Technologies, was merged with Respironics in 1995, and Respironics was sold in 2008 to Phillips Healthcare.

Mr. Petit received his Bachelor's degree in Mechanical Engineering and Master of Science degree in Engineering Mechanics from Georgia Institute of Technology and an MBA degree in Finance from Georgia State University. At Georgia Tech, Mr. Petit funded a professorial chair for "Engineering in Medicine", endowed the Petit Institute for Bioengineering and Bioscience, and assisted with the funding of the Biotechnology Building which bears his name. At Georgia State University, he assisted with the funding of the Science Center building which also bears his name. In 1994, he was inducted into the Technology Hall of Fame of Georgia. In 2007, he was inducted into the Georgia State Business School Hall of Fame. Mr. Petit has previously served as a member of the Board of Directors of the Georgia Research Alliance which is chartered by the State of Georgia to promote high technology and scientific development in the State. He has also previously served on several public company Boards of Directors.


Board of Directors       

Steve Gorlin  • Founder of MiMedx Group, Inc. • Founder of several biotechnology/pharmaceutical companies, including HycorBiomedical, Theragenics(NYSE:TGX), CytRx(Nasdaq:CYTR), MedicisPharmaceutical (NYSE:MRX), EntreMed(Nasdaq:ENMD), Surgi-Vision, DARA BioSciences, (Nasdaq:DARA), SpineMedica and Medivation(Nasdaq: MDVN)       

Charles Koob  • Successful M&A, Anti-trust, Corporate attorney at Simpson Thatcher and Bartlett • Experience includes the defense of Appleton Papers, representation of Virgin Atlantic Airways, and the representation of a special committee of Archr Daniels Midland in a federal grand jury investigation of price-fixing       

Larry Papasan  • Venture Partner at MB Venture Partners • Former President of Smith & Nephew Orthopedics • Chairman at BioMimetic Therapeutics (Nasdaq:BMTI), Board Member at Memphis Biotech Group and Plough Foundation • Chairman at Lebonheur Children's Hospital Foundation, Pres. of the Board at the Biblical Resource Center & Museum       

Joseph G. Bleser  • Experienced Healthcare Exec, CFO, Board member, Audit Chair • Over 20 years as CFO of Public Healthcare & Technology companies • Companies include: HBO, Healthdyne Information Enterprises, Allegiant Physician Svs, Healthcare.com, Transcend Services • BOD: Transcend Services (NASDAQ: TRCR), Matria Healthcare • Licensed CPA with 10 yrs public accounting for international firm       

Terry Dewberry  • Experienced Healthcare Exec, Board member, Audit Chair • Previously Director of Respironics, and Matria Healthcare • Currently on Board of DrTango, a private multicultural communications and health management company • Previously, Director, Vice Chairman, President and COO, and CFO of Healthdyne, 1981 -1996 • Experience buy & sell side Corp M&A, transactions up to $5 billion


 


AmnioFix® is a dehydrated human amniotic membrane processed through Surgical Biologic's proprietary Purion®process, which combines cleaning, dehydration and sterilization to produce a safe, technically sterilized tissue allowing for storage at room temperature.AmnioFix® is processed from human tissue according to the American Association of Tissue Banks (AATB) standards, and is considered a tissue product under Section 361 of the Public Health Service Act. This means that AmnioFix® is regulated differently than the other two MiMedx platform technologies, CollaFix™ and HydroFix®, which are regulated as medical devices and therefore need FDA clearances prior to marketing in the United States. Since it is regulated as a tissue product, AmnioFix® does not need such clearance or approval in the United States.

Injectable Micronized Amniotic Membrane Allograft for Enhanced Soft Tissue Healing

AmnioFix® Injectable is composed of a micronized dehydrated amniotic membrane that provides essential growth factors for enhanced soft tissue healing.
Delivers Essential Growth Factors and Extracellular Matrix Proteins Like Collagen
Reduces Inflammation
Enhances Healing
Injectable Formulation for Easy Application into Deep Soft Tissues
Stores at Room Temperature for up to 5 Years
Available in 3 sizes (0.5cc, 1.25cc, 2.0cc)

Applications for AmnioFix Injectable include:

Tendonitis (inflamed tendon such as "tennis or golfers elbow")
Other Inflamed Soft Tissues Such as Bursitis and Fasciitis

Muscle Sprains
Around the Periphery of a Chronic Ulcer or Burn
Long/Deep Surgical Incisions




EpiFix® is a biologic Human Amniotic Membrane processed through Surgical Biologic's proprietary Purion®process, which combines cleaning, dehydration and sterilization to produce a safe, technically sterilized tissue allowing for storage at room temperature.  EpiFix® is processed from Human tissue according to the American Association of Tissue Banks (AATB) standards, and is considered a tissue product under Section 361 of the Public Health Service Act. This means that EpiFix® is regulated differently than the other two MiMedx platform technologies, CollaFix™ and HydroFix®, which are regulated as Medical Devices and therefore need FDA clearances prior to marketing in the United States. Since it is regulated as a Tissue product, EpiFix® does not need such clearance or approval in the United States.

The New Foundation for Tissue Regeneration
An Amniotic Membrane Allograft for  Chronic and Acute Wound Healing

Delivers Essential Wound Healing Growth Factors
Enhance Healing
Reduces Inflammation and Scar Tissue Formation
Stores at Room Temperature for up to 5 Years
Available in 4 sizes
Growth factors present in EpiFix®*:

Epidermal Growth Factor (EGF)
Promotes proliferation of epithelial cells
Transforming Growth Factor - β (TGF-β)
Anti-inflammatory, and promotes normal wound healing and reduced scar formation
Fibroblast Growth Factor (FGF)
Promotes cellular proliferation & important for collagen matrix formation
Platelet Derived Growth Factor A & B (PDGF A & B)
Promotes cell proliferation in connective tissue & enhances soft tissue healing



 

                  MIMEDX PHYSICIAN ADVISORY BOARD   James Andrews, MD - Chairman 
                   Leon E Paulos, MD 
                   Neal Elattrache, MD 
                   Timothy Kremchek, MD 
Quantum
MDXG
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDXG News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/13/2018 04:04:49 PM
MDXG News: Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Service... 11/07/2018 05:57:00 PM
MDXG News: Current Report Filing (8-k) 11/07/2018 05:16:04 PM
MDXG News: Securities Registration (section 12(g)) (8-a12g) 11/07/2018 04:58:23 PM
MDXG News: Current Report Filing (8-k) 11/07/2018 08:25:32 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#213   Yep...and mdxg has been delisted from nasdaq and GuTA 11/13/18 06:17:20 PM
#212   MDXG delisted from the Nasdaq to the OTC: Renee 11/07/18 04:55:37 PM
#211   * * $MDXG Video Chart 11-07-18 * * ClayTrader 11/07/18 04:39:18 PM
#210   Summers over Sammy Beefkins 10/13/18 10:49:50 AM
#209   Heading to 0 soon First Crown Research 10/11/18 03:11:19 PM
#208   LOL NYSal 10/08/18 07:56:27 AM
#207   $mdxg $10 coming soon. Shane Chowdhury 09/27/18 11:18:16 PM
#206   * * $MDXG Video Chart 08-29-18 * * ClayTrader 08/29/18 04:43:19 PM
#205   MDXG NEWS: " MiMedx Announces Publication Of Phase instock58 08/02/18 09:25:36 AM
#204   MDXG Knock Knock, Anyone home? 8 days ago instock58 07/28/18 01:42:42 PM
#203   * * $MDXG Video Chart 07-26-18 * * ClayTrader 07/26/18 04:21:20 PM
#202   not $3.25--$4.25 TONYM 07/26/18 12:14:15 PM
#201   * * $MDXG Video Chart 07-25-18 * * ClayTrader 07/25/18 05:18:11 PM
#200   Noooooooo. LOL bleedpurple 07/19/18 09:19:57 PM
#199   * * $MDXG Video Chart 07-19-18 * * ClayTrader 07/19/18 05:06:15 PM
#198   There goes 3.25 GuTA 07/16/18 02:09:40 PM
#197   still did not answer where you found MDXG TONYM 07/15/18 06:05:44 PM
#196   Hey man, buy long... I sell short to you. GuTA 07/15/18 05:16:56 PM
#195   ATT (T) fell from $40 to $31 in TONYM 07/15/18 05:08:38 PM
#194   Do you really need more proof? 10 to GuTA 07/15/18 03:42:05 PM
#193   $18 to $3 in 6 months, but where TONYM 07/15/18 03:15:57 PM
#192   It’s in the chart.. $10 to $3 in GuTA 07/15/18 01:01:42 PM
#191   Where on the form 3 for David does TONYM 07/14/18 10:58:16 PM
#190   Selling.. co is going Bk GuTA 07/14/18 04:38:51 PM
#189   Why did David James Coles file a SEC TONYM 07/13/18 04:51:09 PM
#188   What the low down on this? pennystockpro32 07/13/18 10:14:15 AM
#187   How lowwwww can we go? TONYM 07/02/18 10:16:11 AM
#186   * * $MDXG Video Chart 06-07-18 * * ClayTrader 06/07/18 05:05:24 PM
#185   Delay in quarterly report 5/10/18 XenaLives 05/14/18 08:58:54 AM
#184   MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper XenaLives 05/14/18 08:58:30 AM
#183   Hmmm VA incident, but does not indict the company... XenaLives 05/14/18 08:50:44 AM
#182   Institutional interest at 78% XenaLives 05/14/18 08:48:27 AM
#181   MiMedx actively fighting short selling campaign: XenaLives 05/14/18 08:42:44 AM
#180   Just beginning to look into this - News XenaLives 05/14/18 08:41:17 AM
#178   Link to News tab ???? TONYM 04/10/18 07:11:50 PM
#177   News tab MyzStreet 04/10/18 05:52:57 PM
#176   Link please. TONYM 04/10/18 05:44:33 PM
#175   Amniofix trials imo MyzStreet 04/10/18 05:20:32 PM
#174   What is HUGH? Link please. TONYM 04/10/18 04:50:52 PM
#173   Going to be HUGE! Future of medicine! MyzStreet 04/10/18 03:08:49 PM
#172   How are those puts going for you? capitalkid 03/08/18 12:27:30 PM
#171   I sold @$9.04 last week. $5 would be Global Supermodel 03/01/18 07:27:10 AM
#170   looks like it's going to $5 or lower. Thinkforyourself 03/01/18 06:40:06 AM
#169   Someone bought $1.3 million at $8.75. Massive Global Supermodel 02/20/18 05:27:06 PM
#168   In $8.96 Global Supermodel 02/20/18 03:38:02 PM
#167   Huge GAP Down on rising volume stockcharts.com/c-sc/sc?s=mdxg&p=D&b=5&g=0&i $treet $inatra 02/20/18 01:05:19 PM
#166   uh oh things looking really bad for mimedix... Thinkforyourself 02/07/18 01:41:05 PM
#165   Like this run! Go Pete Go bleedpurple 01/26/18 01:47:04 PM
#164   What is the real story behind this guys BudFoxWallStreet 01/23/18 11:48:36 AM
#163   Remember, Mondays and Wednesdays are potential news days! CATTDOGG12347 05/23/17 09:48:38 AM
PostSubject